MannKind Corp. buy BiotechBee
Start price
08.09.24
/
60%
€5.49
Target price
28.02.27
€7.00
Performance (%)
17.70%
End price
14.12.24
€6.46
Summary
This prediction ended on 14.12.24 with a price of €6.46. The BUY prediction by BiotechBee finished with a performance of 17.70%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| MannKind Corp. | -1.994% | -1.994% | -56.271% |
| iShares Core DAX® | -1.665% | -10.870% | -0.717% |
| iShares Nasdaq 100 | -3.766% | -5.147% | 13.412% |
| iShares Nikkei 225® | -2.803% | -11.299% | 25.461% |
| iShares S&P 500 | -2.299% | -4.801% | 8.938% |
According to BiotechBee what are the pros and cons of MannKind Corp. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year